Cytokinetics | CYTK - Market Capitalization


Cytokinetics reported $8.06B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Amgen USD 201.45B 25.2B Feb/2026
Arca Biopharma USD 45M 339M Jun/2025
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
Brainstorm Cell Therapeutics USD 29M 19M Jun/2025
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Capricor Therapeutics USD 207M 227M Jun/2025
Cytokinetics USD 8.06B 1.49B Feb/2026
Eisai JPY 1.43T 119.2B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Exelixis USD 12.27B 523M Feb/2026
Geron USD 874M 24M Sep/2025
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025